Shanmugam Nandhinee R, Muthukumar Sriram, Prasad Shalini
Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.
Enlisense LLC, Allen, TX 75013, USA.
Future Sci OA. 2017 Jun 7;3(4):FSO196. doi: 10.4155/fsoa-2017-0006. eCollection 2017 Nov.
Over the past few decades zinc oxide (ZnO)-based thin films and nanostructures have shown unprecedented performance in a wide range of applications. In particular, owing to high isoelectric point, biocompatibility and other multifunctional characteristics, ZnO has extensively been studied as a transduction material for biosensor development. The fascinating properties of ZnO help retain biological activity of the immobilized biomolecule and help in achieving enhanced sensing performance. As a consequence of recent advancements in this multidisciplinary field, diagnostic biosensors are expanding beyond traditional clinical labs to point-of-care and home settings. Label-free electrical detection of biomarkers has been demonstrated using ZnO-sensing platforms. In this review we highlight the characteristics of ZnO that enable realization of its use in development of point-of-care biosensors toward disease diagnosis, in particular cardiovascular diseases.
在过去几十年中,基于氧化锌(ZnO)的薄膜和纳米结构在广泛的应用中展现出了前所未有的性能。特别是,由于其高的等电点、生物相容性和其他多功能特性,ZnO作为生物传感器开发的转导材料受到了广泛研究。ZnO迷人的特性有助于保留固定化生物分子的生物活性,并有助于实现增强的传感性能。作为这个多学科领域近期进展的结果,诊断生物传感器正从传统临床实验室扩展到即时检测和家庭环境。使用ZnO传感平台已经证明了对生物标志物的无标记电学检测。在这篇综述中,我们重点介绍了ZnO的特性,这些特性使其能够用于开发用于疾病诊断,特别是心血管疾病诊断的即时检测生物传感器。